Iridex Corp IRIX

$0.70 +1.72% at last close
Market Cap$12.29 million
P/E Ratio—
Div Yield—
Volume178.9K
52-Week Range $0.61$1.65

Key Stats

Today's Range
$0.67 – $0.73
50-Day Range
$0.61 – $1.02
52-Week Range
$0.61 – $1.65
Volume
179K shs
Average Volume
739K shs
Market Cap
$12.29 million
P/E Ratio
—
Dividend Yield
—

Short Interest

Short Interest
1.23%
Days to Cover
9.98

About Iridex Corp

IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Employees
108
Exchange
XNAS
Listed
1996-02-16

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.